secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2024-07-25T23:59:59+00:00
Accession:  0001193125-24-184817
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics CFO Leone Patterson resigning effective Aug 14, 2024
------------------------------------------------------------------------

- Leone Patterson, Chief Financial and Business Officer, resigns to pursue another opportunity; will remain until August 14, 2024.
- Resignation is not due to any disagreement with Tenaya on financials, operations, policies, or practices.
- Company has initiated a search for a new Chief Financial Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524184817/0001193125-24-184817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524184817/d868248d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-184817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer